Clinical Studies
![](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q1-2018/clinical-studies/_jcr_content/maincontent-par/image.img.intouch_nl_banner_en_3_645x175px_eu.jpg)
WATCHMAN™ LAAC Device: New PREVAIL 5 Year Data from TCT and 5 Year Meta-Analysis results published in JACC
![](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q1-2018/clinical-studies/_jcr_content/maincontent-par/image_0.img.watchman_prevail_centered_470x249px_eu.jpg)
TCT 2017:
FAME 2 Trial 3-year Outcome and
cost-effectiveness of FFR
![](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q1-2018/clinical-studies/_jcr_content/maincontent-par/image_1.img.banner_issue_7_topic_3_2_960x480px_eu.jpg)
SYNERGY™ BP Stent: outstanding results from the Swedish SCAAR Registry
![](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q1-2018/clinical-studies/_jcr_content/maincontent-par/image_4.img.banner_issue_7_topic_3_3_960x480px_eu.jpg)
* Two strokes in PREVAIL are excluded because the baseline MRS score was unavailable
1. Reddy VY, 5-Year Outcomes After Left Atrial Appendage Closure From the PREVAIL and PROTECT AF Trials. DOI: 10.1016/j.jacc.2017.10.021
2. Sarno, G., et al. Cathet. Cardiovasc. Intervent.. doi:10.1002/ccd.27030